Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NOKOMIS, Fla.--(BUSINESS WIRE)--As part of the company’s push to carve out a share of the $142 billion U.S. drug delivery market, Rainbow Coral Corp. (OTCBB: RBCC) opened talks this week to potentially partner with an emerging innovator in the transdermal delivery sector. Transdermal patches are an increasingly popular drug delivery system that is being developed for everything from contraception to Parkinson’s disease. Transdermal drug delivery prevents many of the problems associated with oral and intravenous routes and offer major advantages such as improved bioavailability, more uniform plasma levels, longer duration of action, reduced side effects and improved therapy.
Help employers find you! Check out all the jobs and post your resume.
